Testing Lupatadine for dust mite allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new tablet (Lupatadine Fumarate) for people with nasal allergies caused by dust mites. It looks at how well the medicine works and what it does in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have allergic rhinitis (nasal allergies) and a positive test for dust mite allergy
- You have not taken steroids, allergy medicines, or other drugs that affect the immune system in the last month
- You do not have other nose conditions like chronic sinusitis, nasal polyps, or a history of nose surgery
- You do not have other immune or allergic diseases, or serious heart, lung, or bleeding problems
- You are not pregnant and you do not smoke
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new allergy shot that may reduce symptoms of dust mite allergies, like sneezing, runny nose, and itchy eyes. It might also help with mild asthma caused by dust mites.
This trial tests a new way to treat cat allergies by giving tiny injections directly into a lymph node (a part of your immune system), instead of under the skin. It aims to see if this method is safe and can reduce cat allergy symptoms, even in people with asthma.
This study tests a daily under-the-tongue tablet or drops to reduce allergy symptoms caused by house dust mites. If you have allergic rhinitis and are bothered by dust mites, this treatment might help your nose feel better without needing shots.
This study looks at how sublingual immunotherapy tablets, which are placed under the tongue, affect the body's response to dust mite allergies in people with allergic rhinitis. The goal is to understand how these tablets might change the immune system and help improve symptoms.
This study tests a new drug called dihydroartemisinin, which comes from a traditional Chinese medicine, to see if it is safe and effective for treating discoid lupus erythematosus (a type of lupus that causes skin rashes and scars). The drug is given as a tablet and is compared to an existing treatment.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.